Latest news
Bright Minds: BMB-101 Takes Center Stage Ahead Of Phase 3 Pivotal Trials (NASDAQ:DRUG) - Seeking AlphaSeeking Alpha · Mon, 10 Aug 2026 12:23:27 GMTDefinium Therapeutics Doles Out Inducement Options to New Staff Ahead of Q2 Report - finance.biggo.comfinance.biggo.com · Thu, 06 Aug 2026 18:28:00 GMTAmgen: First $10 Billion Quarter, More Growth Ahead (NASDAQ:AMGN) - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 18:21:17 GMTKYMR: KT-621 and KT-579 advance rapidly, with $1.5B cash runway supporting late-stage pipeline - TradingViewTradingView · Wed, 05 Aug 2026 15:15:25 GMTUniquity Bio Appoints Jason Moore SVP of Regulatory & Quality Ahead of Late-Stage Solrikitug Development - citybizcitybiz · Tue, 28 Jul 2026 07:00:00 GMT